Sergio Carmona to Male
This is a "connection" page, showing publications Sergio Carmona has written about Male.
Connection Strength
0,679
-
Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa. PLoS Med. 2018 06; 15(6):e1002589.
Score: 0,067
-
Persistent High Burden of Advanced HIV Disease Among Patients Seeking Care in South Africa's National HIV Program: Data From a Nationwide Laboratory Cohort. Clin Infect Dis. 2018 03 04; 66(suppl_2):S111-S117.
Score: 0,066
-
Field Evaluation of Performance of Alere and Cepheid Qualitative HIV Assays for Pediatric Point-of-Care Testing in an Academic Hospital in Soweto, South Africa. J Clin Microbiol. 2017 11; 55(11):3227-3235.
Score: 0,064
-
HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa. J Antimicrob Chemother. 2017 01; 72(1):210-219.
Score: 0,060
-
Balance disorders in childhood: Main etiologies according to age. Usefulness of the video head impulse test. Int J Pediatr Otorhinolaryngol. 2016 Aug; 87:148-53.
Score: 0,058
-
Lower frequency of NPM1 and FLT3-ITD mutations in a South African adult de novo AML cohort. Int J Lab Hematol. 2014 Dec; 36(6):656-64.
Score: 0,050
-
Galvanic vestibular stimulation improves the results of vestibular rehabilitation. Ann N Y Acad Sci. 2011 Sep; 1233:E1-7.
Score: 0,042
-
Effectiveness of a task-sharing collaborative care model for the detection and management of depression among adults receiving antiretroviral therapy in primary care facilities in South Africa: A pragmatic cluster randomised controlled trial. J Affect Disord. 2025 Feb 01; 370:499-510.
Score: 0,026
-
Impact of Viral Load Monitoring on Retention and Viral Suppression: A Regression Discontinuity Analysis of South Africa's National Laboratory Cohort. Am J Epidemiol. 2020 12 01; 189(12):1492-1501.
Score: 0,020
-
High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia. Medicine (Baltimore). 2020 Sep 11; 99(37):e21661.
Score: 0,020
-
Delays in repeat HIV viral load testing for those with elevated viral loads: a national perspective from South Africa. J Int AIDS Soc. 2020 07; 23(7):e25542.
Score: 0,019
-
Drug level testing as a strategy to determine eligibility for drug resistance testing after failure of ART: a retrospective analysis of South African adult patients on second-line ART. J Int AIDS Soc. 2020 06; 23(6):e25501.
Score: 0,019
-
Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study. PLoS Med. 2020 02; 17(2):e1003037.
Score: 0,019
-
Adolescent HIV treatment in South Africa's national HIV programme: a retrospective cohort study. Lancet HIV. 2019 11; 6(11):e760-e768.
Score: 0,018
-
Improving Linkage to and Retention in Care in Newly Diagnosed HIV-Positive Patients Using Smartphones in South Africa: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2019 04 02; 7(4):e12652.
Score: 0,018
-
Human Immunodeficiency Virus (HIV) Drug Resistance in African Infants and Young Children Newly Diagnosed With HIV: A Multicountry Analysis. Clin Infect Dis. 2017 Nov 29; 65(12):2018-2025.
Score: 0,016
-
Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study. Lancet Infect Dis. 2018 02; 18(2):188-197.
Score: 0,016
-
Improving early identification of HIV-infected neonates with birth PCR testing in a large urban hospital in Johannesburg, South Africa: successes and challenges. J Int AIDS Soc. 2017 04 10; 20(1):21436.
Score: 0,015
-
Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study. BMC Health Serv Res. 2017 Jan 17; 17(1):41.
Score: 0,015
-
Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey. PLoS One. 2016; 11(12):e0166305.
Score: 0,015
-
High prevalence of the K65R mutation in HIV-1 subtype C infected patients failing tenofovir-based first-line regimens in South Africa. PLoS One. 2015; 10(2):e0118145.
Score: 0,013
-
A serious parvovirus B19 genotype 2 infection not detected in a commercial PCR assay. J Clin Virol. 2014 May; 60(1):70-2.
Score: 0,012
-
Characterization of Lymphomas in a high prevalence HIV setting. J Acquir Immune Defic Syndr. 2010 Apr; 53(5):656-60.
Score: 0,010